Zoledronic acid increases the expression of IL-1β in an NLRP3/caspase-1-dependent manner in LPS-primed BMDMs from mice with diabetes mellitus, and NLRP3 inhibitors improve oral wound healing and suppress osteonecrosis of the jaw in these mice (127). The gene discussed is IL1B; the disease is diabetes mellitus.